Raymond Prudo-Chlebosz - Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Issuer Symbol: AKTX on Nasdaq
All Insider Reports: All Insider Reports

Raymond Prudo-Chlebosz - trading volume in the past year for Akari Therapeutics Plc

	Shares	%	Avg Price	Total $
Buys	+1,005,319	100%	$0.4041	+$406,249
Sells
Net	+1,005,319	100%		+$406,249

Holdings reported by Raymond Prudo-Chlebosz for Akari Therapeutics Plc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
American Depositary Shares representing Ordinary Shares	2,484,990	$2,783,189	$1.12	20 Mar 2025	Direct
Series A Warrants (Right to Buy)	446,428	$499,999	$1.12	06 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy)	446,428	$499,999	$1.12	06 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares
American Depositary Shares representing Ordinary Shares	400,383	$448,429	$1.12	20 Mar 2025	RPC Pharma Limited
Pre-Funded Warrants to purchase ADRs	386,661	$156,249	$0.4041	16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
American Depositary Shares representing Ordinary Shares	19,355	$21,678	$1.12	20 Mar 2025	Praxis Trustees Limited
Warrants to purchase American Depositary Shares ("ADRs")	618,658			16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
Warrants to purchase ADRs	386,661			16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
Stock Option (Right to Buy)	225,000			20 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares

Transactions reported by Raymond Prudo-Chlebosz for Akari Therapeutics Plc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.